Home Column

Column

healthcare, private equity, medicine
This month we saw activity in a segment of the dental field that’s largely flown under the radar. Of course, private equity’s love for all things dental is no secret. Rather, it’s among the most hotly pursued areas and the most mature areas of investment in retail health. But most activity we’re talking about involves […]
private equity, Chris Witkowsky
LPs are a conservative bunch. As much as they complain about the things they don’t like about GPs, they’re not big on change. And not much will prevent them from opening their wallets to the best performing managers. This is the case with a lot of issues in the PE world — fee structures, for […]
How the ‘selfie obsession’ is making waves in the dental market
private equity, Chris Witkowsky
I can’t tell you how many times I’ve heard that one of the vital aspects limited partners want to see out of a debut firm is that the new manager is building a business, not just collecting money to go invest. Creating a robust back office capable of handling legal, accounting and compliance issues is […]
healthcare, private equity, medicine
Sponsors look to reinvent urgent care
private equity, Chris Witkowsky
Welcome to our quarterly wrap-up issue, which could just as well be called “view from the peak.” What we saw in the second quarter — just like in the first quarter — is strong deal activity driven by aggressive general partners and hyper fundraising boosted by hungry limited partners. It’s all a function of the strong markets […]
healthcare, private equity, medicine
Late night with Press Ganey: No Drama
Key-person provisions lately are a hotly debated topic, with some GPs setting up several individuals, rather than one or two, as key people on a fund. This has the effect, at least from the LP perspective, of diluting the impact of a key-person provision. After all, a key-person provision that names one or two people […]
healthcare, private equity, medicine
As Goldman writes big check in eye care, others steer clear of retail health
healthcare, private equity, medicine
Will the buzz around ‘Social Determinants of Health’ translate to PE investment?
pehub
pehub

Copyright PEI Media

Not for publication, email or dissemination